AbbVie Inc.ABBVNYSE
LOADING
|||
EPS Growth Under Pressure
Trending lower, below historical average.
Left:
||||
Year-over-year earnings per share growth rate
Latest
-81.13%
↓ 111% below average
Average (39q)
705.66%
Historical baseline
Range
High:17599.12%
Low:-167.40%
CAGR
NaN%
Modest growth trend
| Period | Value |
|---|---|
| Q3 2025 | -81.13% |
| Q2 2025 | -26.39% |
| Q1 2025 | 4077.90% |
| Q4 2024 | -102.06% |
| Q3 2024 | 14.29% |
| Q2 2024 | 0.00% |
| Q1 2024 | 67.39% |
| Q4 2023 | -54.00% |
| Q3 2023 | -12.28% |
| Q2 2023 | 776.92% |
| Q1 2023 | -90.71% |
| Q4 2022 | -37.22% |
| Q3 2022 | 328.85% |
| Q2 2022 | -79.53% |
| Q1 2022 | 10.92% |
| Q4 2021 | 28.65% |
| Q3 2021 | 323.81% |
| Q2 2021 | -79.00% |
| Q1 2021 | 17599.12% |
| Q4 2020 | -99.13% |
| Q3 2020 | 388.89% |
| Q2 2020 | -122.28% |
| Q1 2020 | 6.88% |
| Q4 2019 | 48.82% |
| Q3 2019 | 159.18% |
| Q2 2019 | -70.30% |
| Q1 2019 | 235.25% |
| Q4 2018 | -167.40% |
| Q3 2018 | 43.65% |
| Q2 2018 | -27.59% |
| Q1 2018 | 5221.10% |
| Q4 2017 | -96.79% |
| Q3 2017 | -15.00% |
| Q2 2017 | 12.15% |
| Q1 2017 | 22.99% |
| Q4 2016 | -10.31% |
| Q3 2016 | -2.02% |
| Q2 2016 | 19.28% |
| Q1 2016 | -11.70% |
| Q4 2015 | 25.33% |